Citations (136)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Zhenyi Jin, Tianbi Lan, Yun Zhao, Jinxia Du, Jie Chen, Jing Lai, Ling Xu, Shaohua Chen, Xueyun Zhong, Xiuli Wu & Yangqiu Li. (2022) Higher TIGIT+CD226- γδ T cells in Patients with Acute Myeloid Leukemia. Immunological Investigations 51:1, pages 40-50.
Read now
Read now
Caroline M Hull & John Maher. (2021) Approaches for refining and furthering the development of CAR-based T cell therapies for solid malignancies. Expert Opinion on Drug Discovery 16:10, pages 1105-1117.
Read now
Read now
Florian Kast, Christian Klein, Pablo Umaña, Alena Gros & Stephan Gasser. (2021) Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies. OncoImmunology 10:1.
Read now
Read now
Pauline Girard, Julie Charles, Camille Cluzel, Emmanuelle Degeorges, Olivier Manches, Joel Plumas, Florence De Fraipont, Marie-Therese Leccia, Stephane Mouret, Laurence Chaperot & Caroline Aspord. (2019) The features of circulating and tumor-infiltrating γδ T cells in melanoma patients display critical perturbations with prognostic impact on clinical outcome. OncoImmunology 8:8.
Read now
Read now
Ignacio Catalan-Serra & Øystein Brenna. (2018) Immunotherapy in inflammatory bowel disease: Novel and emerging treatments. Human Vaccines & Immunotherapeutics 14:11, pages 2597-2611.
Read now
Read now
Maaike V. J. Braham, Monique C. Minnema, Tineke Aarts, Zsolt Sebestyen, Trudy Straetemans, Anna Vyborova, Jurgen Kuball, F. Cumhur Öner, Catherine Robin & Jacqueline Alblas. (2018) Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model. OncoImmunology 7:6.
Read now
Read now
Laura Mondragón, Guido Kroemer & Lorenzo Galluzzi. (2016) Immunosuppressive γδ T cells foster pancreatic carcinogenesis. OncoImmunology 5:11.
Read now
Read now
Jonathan P H Fisher, Barry Flutter, Florian Wesemann, Jennifer Frosch, Claudia Rossig, Kenth Gustafsson & John Anderson. (2016) Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells. OncoImmunology 5:1.
Read now
Read now
Heleen H Van Acker, Sébastien Anguille, Viggo F Van Tendeloo & Eva Lion. (2015) Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy. OncoImmunology 4:8.
Read now
Read now
Jaydeep Bhat & Dieter Kabelitz. (2015) γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?. OncoImmunology 4:6.
Read now
Read now
Florent Guerville, Sophie Daburon, Romain Marlin, Lydia Lartigue, Severine Loizon, Vincent Pitard, Lionel Couzi, Jean-François Moreau, Julie Déchanet-Merville & Benjamin Faustin. (2015) TCR-dependent sensitization of human γδ T cells to non-myeloid IL-18 in cytomegalovirus and tumor stress surveillance. OncoImmunology 4:5.
Read now
Read now
Jonathan Fisher, Anne-Marijn Kramer, Kenth Gustafsson & John Anderson. (2015) Non-V delta 2 gamma delta T lymphocytes as effectors of cancer immunotherapy. OncoImmunology 4:3.
Read now
Read now
Articles from other publishers (124)
Hirohito Kobayashi, Tsunenori Kondo, Junpei Iizuka, Kazuhiko Yoshida & Toshio Takagi. (2023) A retrospective cohort study of the impact of peripheral blood gamma- delta T cells to prognosis of nonmetastatic renal cell cancer after curative resection. Urologic Oncology: Seminars and Original Investigations 41:12, pages 488.e1-488.e9.
Crossref
Crossref
Elisa Zappa, Alice Vitali, Kathleen Anders, Jan J. Molenaar, Judith Wienke & Annette Künkele. (2023) Adoptive cell therapy in paediatric extracranial solid tumours: current approaches and future challenges. European Journal of Cancer 194, pages 113347.
Crossref
Crossref
Jingyi Lu, Chen Huang, Rong He, Rongjia Xie, Yue Li, Xianling Guo, Qian Zhang & Qing Xu. (2023) CD4−/CD8− double-negative tumor-infiltrating lymphocytes expanded from solid tumor tissue suppress the proliferation of tumor cells in an MHC-independent way. Journal of Cancer Research and Clinical Oncology 149:11, pages 9007-9016.
Crossref
Crossref
Kirsty R. Field, Kathleen M. Wragg, Wen Shi Lee, Marc Rigau, Adam P. Uldrich, Stephen J. Kent & Jennifer A. Juno. (2023) Cytokines enhance human Vγ9Vδ2 T‐cell TCR‐dependent and TCR‐independent effector functions. European Journal of Immunology 53:6.
Crossref
Crossref
Marzieh Mazinani & Fatemeh Rahbarizadeh. (2023) New cell sources for CAR-based immunotherapy. Biomarker Research 11:1.
Crossref
Crossref
Jan Vydra, Emilio Cosimo, Petr Lesný, Richard Sebastian Wanless, John Anderson, Alan George Clark, Angela Scott, Emma Kate Nicholson & Michael Leek. (2023) A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 23:5, pages e232-e239.
Crossref
Crossref
Justin C. Boucher, Bin Yu, Gongbo Li, Bishwas Shrestha, David Sallman, Ana Marie Landin, Cheryl Cox, Kumar Karyampudi, Claudio Anasetti, Marco L. Davila & Nelli Bejanyan. (2023) Large Scale Ex Vivo Expansion of γδ T cells Using Artificial Antigen-presenting Cells. Journal of Immunotherapy 46:1, pages 5-13.
Crossref
Crossref
Jiamian Zheng, Dan Qiu, Xuan Jiang, Yun Zhao, Haotian Zhao, Xiaofang Wu, Jie Chen, Jing Lai, Wenbin Zhang, Xutong Li, Yangqiu Li, Xiuli Wu & Zhenyi Jin. (2022) Increased PD-1+Foxp3+ γδ T cells associate with poor overall survival for patients with acute myeloid leukemia. Frontiers in Oncology 12.
Crossref
Crossref
Ala Amgheib, Ruisi Fu & Eric O. Aboagye. (2022) Positron Emission Tomography Probes for Imaging Cytotoxic Immune Cells. Pharmaceutics 14:10, pages 2040.
Crossref
Crossref
Yan Zhou, Qi Tian, Huan Gao, Lizhe Zhu, Jiao Yang, Juan Zhang & Jin Yang. (2022) Correlation Between Immune-Related Genes and Tumor-Infiltrating Immune Cells With the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer. Frontiers in Genetics 13.
Crossref
Crossref
Gabrielle M. Ferry, Charles Agbuduwe, Megan Forrester, Sophie Dunlop, Kerry Chester, Jonathan Fisher, John Anderson & Marta Barisa. (2022) A Simple and Robust Single-Step Method for CAR-Vδ1 γδT Cell Expansion and Transduction for Cancer Immunotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Rosa A. Castillo-Rodríguez, Cristina Trejo-Solís, Alfredo Cabrera-Cano, Saúl Gómez-Manzo & Víctor Manuel Dávila-Borja. (2022) Hypoxia as a Modulator of Inflammation and Immune Response in Cancer. Cancers 14:9, pages 2291.
Crossref
Crossref
Nekisa Zakeri, Andrew Hall, Leo Swadling, Laura J. Pallett, Nathalie M. Schmidt, Mariana O. Diniz, Stephanie Kucykowicz, Oliver E. Amin, Amir Gander, Massimo Pinzani, Brian R. Davidson, Alberto Quaglia & Mala K. Maini. (2022) Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma. Nature Communications 13:1.
Crossref
Crossref
Minu Anoop, Aswathy R. Nambiar, Shantikumar V. Nair, Manzoor Koyakutty & Anusha Ashokan. (2022) Zoledronic acid conjugated calcium phosphate nanoparticles for applications in cancer immunotherapy. Materials Today Communications 30, pages 103065.
Crossref
Crossref
Joseph M. McGraw & Deborah A. Witherden. (2022) γδ T cell costimulatory ligands in antitumor immunity. Exploration of Immunology, pages 79-97.
Crossref
Crossref
Chenxiao Liu, Karolina Skorupinska-Tudek, Sven-Göran Eriksson & Ingela Parmryd. (2022) Potentiating Vγ9Vδ2 T cell proliferation and assessing their cytotoxicity towards adherent cancer cells at the single cell level. Biology Open 11:1.
Crossref
Crossref
Juntao Li, Linqing Sun, Yanjun Chen, Jinghan Zhu, Jin Shen, Jiayu Wang, Yanzheng Gu, Guangbo Zhang, Mingyuan Wang, Tongguo Shi & Weichang Chen. (2021) Gastric cancer-derived exosomal miR-135b-5p impairs the function of Vγ9Vδ2 T cells by targeting specificity protein 1. Cancer Immunology, Immunotherapy 71:2, pages 311-325.
Crossref
Crossref
Chao Wang, Yan Zhang & Wei-Qiang Gao. (2022) The evolving role of immune cells in prostate cancer. Cancer Letters 525, pages 9-21.
Crossref
Crossref
Hannah Kaminski, Lionel Couzi & Matthias Eberl. (2021) Unconventional T cells and kidney disease. Nature Reviews Nephrology 17:12, pages 795-813.
Crossref
Crossref
Samira Aghlara-Fotovat, Amanda Nash, Boram Kim, Robert Krencik & Omid Veiseh. (2021) Targeting the extracellular matrix for immunomodulation: applications in drug delivery and cell therapies. Drug Delivery and Translational Research 11:6, pages 2394-2413.
Crossref
Crossref
Georg von Massow, Steve Oh, Alan Lam & Kenth Gustafsson. (2021) Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections. Frontiers in Immunology 12.
Crossref
Crossref
Haeyoun Choi, Yunkyung Lee, Gaeun Hur, Sang-Eun Lee, Hyun-Il Cho, Hyun-Jung Sohn, Byung Sik Cho, Hee-Je Kim & Tai-Gyu Kim. (2021) γδ T cells cultured with artificial antigen-presenting cells and IL-2 show long-term proliferation and enhanced effector functions compared with γδ T cells cultured with only IL-2 after stimulation with zoledronic acid. Cytotherapy 23:10, pages 908-917.
Crossref
Crossref
Josephine G. M. Strijker, Ronja Pscheid, Esther Drent, Jessica J. F. van der Hoek, Bianca Koopmans, Kimberley Ober, Sander R. van Hooff, Waleed M. Kholosy, Annelisa M. Cornel, Chris Coomans, Andrea Bisso, Marleen M. van Loenen, Jan J. Molenaar & Judith Wienke. (2021) αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I Expression. Journal of Personalized Medicine 11:9, pages 923.
Crossref
Crossref
David A. Rosso, Micaela Rosato, Juan Iturrizaga, Nazareno González, Carolina M. Shiromizu, Irene A. Keitelman, Juan V. Coronel, Fernando D. Gómez, María M. Amaral, Alejandra T. Rabadan, Gabriela V. Salamone & Carolina C. Jancic. (2021) Glioblastoma cells potentiate the induction of the Th1-like profile in phosphoantigen-stimulated γδ T lymphocytes. Journal of Neuro-Oncology 153:3, pages 403-415.
Crossref
Crossref
Xueyan Xi, Yang Guo, Min Zhu, Fen Qiu, Feifei Lei, Gang Li & Boyu Du. (2021) Identification of new potential antigen recognized by γδT cells in hepatocellular carcinoma. Cancer Immunology, Immunotherapy 70:7, pages 1917-1927.
Crossref
Crossref
Rueyhung R. Weng, Hsuan-Hsuan Lu, Chien-Ting Lin, Chia-Chi Fan, Rong-Shan Lin, Tai-Chung Huang, Shu-Yung Lin, Yi-Jhen Huang, Yi-Hsiu Juan, Yi-Chieh Wu, Zheng-Ci Hung, Chi Liu, Xuan-Hui Lin, Wan-Chen Hsieh, Tzu-Yuan Chiu, Jung-Chi Liao, Yen-Ling Chiu, Shih-Yu Chen, Chong-Jen Yu & Hsing-Chen Tsai. (2021) Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer. Nature Communications 12:1.
Crossref
Crossref
Xin Huang, Cunchuan Wang & Ningxia Wang. (2021) Vγ9Vδ2 T cells strengthen cisplatin inhibition activity against breast cancer MDA-MB-231 cells by disrupting mitochondrial function and cell ultrastructure. Cancer Cell International 21:1.
Crossref
Crossref
Deng-Xuan Fan, Ming-Qing Li, Wen-Jie Zhou, Hong-Lan Huang, Hui-Li Yang & Cong-Jian Xu. (2021) A defective CXCL16/CXCR6 axis increases the risk of pregnancy loss via the abnormal crosstalk between decidual γδ t cells and trophoblasts. Reproductive and Developmental Medicine 0:0, pages 0.
Crossref
Crossref
. (2021) Interplay between γδT-Cell Metabolism and Tumour Microenvironment Offers Opportunities for Therapeutic Intervention. Immunometabolism.
Crossref
Crossref
Pauline Girard, Eleonora Sosa Cuevas, Benedicte Ponsard, Stephane Mouret, Hugo Gil, Edwige Col, Florence De Fraipont, Nathalie Sturm, Julie Charles, Olivier Manches, Laurence Chaperot & Caroline Aspord. (2021) Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes. Clinical & Translational Immunology 10:11.
Crossref
Crossref
Juan Carlos Andreu-Ballester, Lorena Galindo-Regal, Julia Hidalgo-Coloma, Carmen Cuéllar, Carlos García-Ballesteros, Carolina Hurtado, Natalia Uribe, María del Carmen Martín, Ana Isabel Jiménez, Francisca López-Chuliá & Antonio Llombart-Cussac. (2020) Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors. PLOS ONE 15:12, pages e0243545.
Crossref
Crossref
Piamsiri Sawaisorn, Korakot Atjanasuppat, Usanarat Anurathapan, Somchai Chutipongtanate & Suradej Hongeng. (2020) Strategies to Improve Chimeric Antigen Receptor Therapies for Neuroblastoma. Vaccines 8:4, pages 753.
Crossref
Crossref
Hachemi KadriTaher E. TaherQin XuMaria SharifElizabeth AshbyRichard T. BryanBenjamin E. Willcox & Youcef Mehellou. (2020) Aryloxy Diester Phosphonamidate Prodrugs of Phosphoantigens (ProPAgens) as Potent Activators of Vγ9/Vδ2 T-Cell Immune Responses. Journal of Medicinal Chemistry 63:19, pages 11258-11270.
Crossref
Crossref
Margarita Bartish, Sonia V. del Rincón, Christopher E. Rudd & H. Uri Saragovi. (2020) Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy. Frontiers in Immunology 11.
Crossref
Crossref
Ying He, Lin Xu, Jingjing Feng, Kangni Wu, Yanmin Zhao & He Huang. (2020) HDAC Inhibitor LBH589 Suppresses the Proliferation but Enhances the Antileukemic Effect of Human γδT Cells. Molecular Therapy - Oncolytics 18, pages 623-630.
Crossref
Crossref
Louis F. Chai, Ethan Prince, Venu G. Pillarisetty & Steven C. Katz. (2019) Challenges in assessing solid tumor responses to immunotherapy. Cancer Gene Therapy 27:7-8, pages 528-538.
Crossref
Crossref
Gabrielle M. Siegers, Indrani Dutta, Eun Young Kang, Jing Huang, Martin Köbel & Lynne-Marie Postovit. (2020) Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity. Frontiers in Immunology 11.
Crossref
Crossref
S K Sureshbabu, D Chaukar & S V Chiplunkar. (2020) Hypoxia regulates the differentiation and anti-tumor effector functions of γδT cells in oral cancer. Clinical and Experimental Immunology 201:1, pages 40-57.
Crossref
Crossref
Rishu Takimoto, Tomoharu Miyashita, Eishiro Mizukoshi, Takashi Kamigaki, Sachiko Okada, Hiroshi Ibe, Eri Oguma, Keiko Naitoh, Kosei Yasumoto, Kaori Makita, Katsuro Tomita & Shigenori Goto. (2020) Identification of prognostic factors for γδT cell immunotherapy in patients with solid tumor. Cytotherapy 22:6, pages 329-336.
Crossref
Crossref
Mahboubeh Yazdanifar, Giulia Barbarito, Alice Bertaina & Irma Airoldi. (2020) γδ T Cells: The Ideal Tool for Cancer Immunotherapy. Cells 9:5, pages 1305.
Crossref
Crossref
Noémie Joalland & Emmanuel Scotet. (2020) Emerging Challenges of Preclinical Models of Anti-tumor Immunotherapeutic Strategies Utilizing Vγ9Vδ2 T Cells. Frontiers in Immunology 11.
Crossref
Crossref
Butsabong Lerkvaleekul, Nopporn Apiwattanakul, Chompunuch Klinmalai, Suradej Hongeng & Soamarat Vilaiyuk. (2019) Age‐related changes in lymphocyte subpopulations in healthy Thai children. Journal of Clinical Laboratory Analysis 34:5.
Crossref
Crossref
Alina S. FichtnerMohindar M. KarunakaranSiyi GuChristopher T. Boughter, Marta T. BorowskaLisa StarickAnna NöhrenThomas W. Göbel, Erin J. AdamsThomas Herrmann. (2020)
Alpaca (
Vicugna pacos
), the first nonprimate species with a phosphoantigen-reactive Vγ9Vδ2 T cell subset
. Proceedings of the National Academy of Sciences 117:12, pages 6697-6707.
Crossref
Crossref
Uyen Thi Trang Than, Huyen Thi Le, Diem Huong Hoang, Xuan-Hung Nguyen, Cuong Thi Pham, Khanh Thi Van Bui, Hue Thi Hong Bui, Phong Van Nguyen, Tu Dac Nguyen, Thu Thi Hoai Do, Thao Thi Chu, Anh Viet Bui, Liem Thanh Nguyen & Nhung Thi My Hoang. (2020) Induction of Antitumor Immunity by Exosomes Isolated from Cryopreserved Cord Blood Monocyte-Derived Dendritic Cells. International Journal of Molecular Sciences 21:5, pages 1834.
Crossref
Crossref
Matthew J. Frank, Niclas Olsson, Andy Huang, Sai-Wen Tang, Robert S. Negrin, Joshua E. Elias & Everett H. Meyer. (2020) A novel antibody-cell conjugation method to enhance and characterize cytokine-induced killer cells. Cytotherapy 22:3, pages 135-143.
Crossref
Crossref
Gerardo A. Vitiello & George Miller. (2020) Targeting the interleukin-17 immune axis for cancer immunotherapy. Journal of Experimental Medicine 217:1.
Crossref
Crossref
Bui Viet Anh, Chu Thi Thao, Pham Thi Cuong, Nguyen Thi Thu Thuy, Hoang Huong Diem, Bui Thi Van Khanh, Bui Thi Hong Hue, Than Thi Trang Uyen, Nguyen Dac Tu, Tran Thi Ton Hoai, Nguyen Lai Thanh, Nguyen Thanh Liem & Hoang Thi My Nhung. (2020) Vγ9γδ T Cell Induction by Human Umbilical Cord Blood Monocytes-Derived, Interferon-α-Stimulated Dendritic Cells. Cancer Control 27:1, pages 107327482097402.
Crossref
Crossref
Xiaomi Li, Huimin Lu, Yanzheng Gu, Xueguang Zhang, Guangbo Zhang, Tongguo Shi & Weichang Chen. (2020) Tim-3 suppresses the killing effect of Vγ9Vδ2 T cells on colon cancer cells by reducing perforin and granzyme B expression. Experimental Cell Research 386:1, pages 111719.
Crossref
Crossref
Christian Peters, Léonce Kouakanou, Hans-Heinrich Oberg, Daniela Wesch & Dieter Kabelitz. 2020. Tumor Immunology and Immunotherapy – Cellular Methods Part A. Tumor Immunology and Immunotherapy – Cellular Methods Part A
223
237
.
Mohammed Alnaggar, Yan Xu, Jingxia Li, Junyi He, Jibing Chen, Man Li, Qingling Wu, Li Lin, Yingqing Liang, Xiaohua Wang, Jiawei Li, Yi Hu, Yan Chen, Kecheng Xu, Yangzhe Wu & Zhinan Yin. (2019) Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Cynthia Chauvin, Noémie Joalland, Jeanne Perroteau, Ulrich Jarry, Laura Lafrance, Catherine Willem, Christelle Retière, Lisa Oliver, Catherine Gratas, Laetitia Gautreau-Rolland, Xavier Saulquin, François M. Vallette, Henri Vié, Emmanuel Scotet & Claire Pecqueur. (2019) NKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma Cells. Clinical Cancer Research 25:23, pages 7218-7228.
Crossref
Crossref
Yin Wu, Fernanda Kyle-Cezar, Richard T. Woolf, Cristina Naceur-Lombardelli, Julie Owen, Dhruva Biswas, Anna Lorenc, Pierre Vantourout, Patrycja GazinskaAnita Grigoriadis, Andrew Tutt & Adrian Hayday. (2019)
An innate-like Vδ1
+
γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer
. Science Translational Medicine 11:513.
Crossref
Crossref
Chakradhar Yakkala, Cheryl Lai-Lai Chiang, Lana Kandalaft, Alban Denys & Rafael Duran. (2019) Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors. Frontiers in Immunology 10.
Crossref
Crossref
José Rivera-Torres & Esther San José. (2019) Src Tyrosine Kinase Inhibitors: New Perspectives on Their Immune, Antiviral, and Senotherapeutic Potential. Frontiers in Pharmacology 10.
Crossref
Crossref
Jonathan Fisher, Roshan SharmaDilu Wisidagamage Don, Marta Barisa, Marina Olle Hurtado, Pierre AbramowskiLucy Porter, William DayRoberto Borea, Sarah InglottJohn Anderson & Dana Pe’er. (2019) Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors. Science Signaling 12:598.
Crossref
Crossref
RUI LI, RACHEL JOHNSON, GUANGLIN YU, DAVID H. MCKENNA & ALLISON HUBEL. (2019) Preservation of cell-based immunotherapies for clinical trials. Cytotherapy 21:9, pages 943-957.
Crossref
Crossref
Hang Jiang, Zhao Yang, Zhenyu Song, Mark Green, Haihan Song & Qinghua Shao. (2019) γδ T cells in hepatocellular carcinoma patients present cytotoxic activity but are reduced in potency due to IL-2 and IL-21 pathways. International Immunopharmacology 70, pages 167-173.
Crossref
Crossref
Hui Chen, Mingjin Zou, Da Teng, Yu Hu, Jianmin Zhang & Wei He. (2018) Profiling the pattern of the human T-cell receptor γδ complementary determinant region 3 repertoire in patients with lung carcinoma via high-throughput sequencing analysis. Cellular & Molecular Immunology 16:3, pages 250-259.
Crossref
Crossref
Francis Man, Lindsay Lim, Alessia Volpe, Alberto Gabizon, Hilary Shmeeda, Benjamin Draper, Ana C. Parente-Pereira, John Maher, Philip J. Blower, Gilbert O. Fruhwirth & Rafael T.M. de Rosales. (2019) In Vivo PET Tracking of 89Zr-Labeled Vγ9Vδ2 T Cells to Mouse Xenograft Breast Tumors Activated with Liposomal Alendronate. Molecular Therapy 27:1, pages 219-229.
Crossref
Crossref
Elizabeth S. Morrow, Antonia Roseweir & Joanne Edwards. (2019) The role of gamma delta T lymphocytes in breast cancer: a review. Translational Research 203, pages 88-96.
Crossref
Crossref
Maliha Khan, Rabbia Siddiqi, Elizabeth J. Shpall & Amanda Olson. 2019. Hematopoietic Cell Transplantation for Malignant Conditions. Hematopoietic Cell Transplantation for Malignant Conditions
395
416
.
Anupa Kudva & Shakeel Modak. 2019. Neuroblastoma. Neuroblastoma
147
173
.
Xichun Xia, Wei Zhou, Chengbin Guo, Zhen Fu, Leqing Zhu, Peng Li, Yan Xu, Liangyan Zheng, Hua Zhang, Changliang Shan & Yunfei Gao. (2018) Glutaminolysis Mediated by MALT1 Protease Activity Facilitates PD-L1 Expression on ABC-DLBCL Cells and Contributes to Their Immune Evasion. Frontiers in Oncology 8.
Crossref
Crossref
Oliver McCallion, Joanna Hester & Fadi Issa. (2018) Deciphering the Contribution of γδ T Cells to Outcomes in Transplantation. Transplantation 102:12, pages 1983-1993.
Crossref
Crossref
Mingyao Meng, Lin Li, Ruhong Li, Wenju Wang, Yang Chen, Yanhua Xie, Rui Han, Kai Zhu, Wenwen Huang, Lili Yang, Shuo Li, Jianlin Shi, Weiwei Tan, Hui Gao, Yiyi Zhao, Li Yang, Jing Tan & Zongliu Hou. (2018) A dynamic transcriptomic atlas of cytokine-induced killer cells. Journal of Biological Chemistry 293:51, pages 19600-19612.
Crossref
Crossref
David Vermijlen, Deborah Gatti, Ariadni Kouzeli, Teja Rus & Matthias Eberl. (2018) γδ T cell responses: How many ligands will it take till we know?. Seminars in Cell & Developmental Biology 84, pages 75-86.
Crossref
Crossref
Lin Ye, Yuqing Lou, Liming Lu & Xiaohong Fan. (2018) Mesothelin‑targeted second generation CAR‑T cells inhibit growth of mesothelin‑expressing tumors in�vivo. Experimental and Therapeutic Medicine.
Crossref
Crossref
Yueshui Zhao, Ling Lin, Zhangang Xiao, Mingxing Li, Xu Wu, Wanping Li, Xiaobing Li, Qijie Zhao, Yuanlin Wu, Hanyu Zhang, Jianhua Yin, Lingling Zhang, Chi Hin Cho & Jing Shen. (2018)
Protective Role of
γδ
T Cells in Different Pathogen Infections and Its Potential Clinical Application
. Journal of Immunology Research 2018, pages 1-15.
Crossref
Crossref
M R Pranzatelli, T J Allison, N R McGee & E D Tate. (2018) Cerebrospinal fluid γδ T cell frequency is age-related: a case–control study of 435 children with inflammatory and non-inflammatory neurological disorders. Clinical and Experimental Immunology 193:1, pages 103-112.
Crossref
Crossref
Jonathan Fisher & John Anderson. (2018) Engineering Approaches in Human Gamma Delta T Cells for Cancer Immunotherapy. Frontiers in Immunology 9.
Crossref
Crossref
Gabrielle M. Siegers, Indrani Dutta, Raymond Lai & Lynne-Marie Postovit. (2018) Functional Plasticity of Gamma Delta T Cells and Breast Tumor Targets in Hypoxia. Frontiers in Immunology 9.
Crossref
Crossref
C. David Pauza, Mei-Ling Liou, Tyler Lahusen, Lingzhi Xiao, Rena G. Lapidus, Cristiana Cairo & Haishan Li. (2018) Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local. Frontiers in Immunology 9.
Crossref
Crossref
Zhan Wang, Zenan Wang, Shu Li, Binghao Li, Lingling Sun, Hengyuan Li, Peng Lin, Shengdong Wang, Wangsiyuan Teng, Xingzhi Zhou & Zhaoming Ye. (2018) Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis. Frontiers in Immunology 9.
Crossref
Crossref
Heleen H. Van Acker, Diana Campillo-Davo, Gils Roex, Maarten Versteven, Evelien L. Smits & Viggo F. Van Tendeloo. (2018) The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy. Cytokine & Growth Factor Reviews 41, pages 54-64.
Crossref
Crossref
André E. Simões, Biagio Di Lorenzo & Bruno Silva-Santos. (2018) Molecular Determinants of Target Cell Recognition by Human γδ T Cells. Frontiers in Immunology 9.
Crossref
Crossref
Timm Hoeres, Manfred Smetak, Dominik Pretscher & Martin Wilhelm. (2018) Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer. Frontiers in Immunology 9.
Crossref
Crossref
Rupert Handgretinger & Karin Schilbach. (2018) The potential role of γδ T cells after allogeneic HCT for leukemia. Blood 131:10, pages 1063-1072.
Crossref
Crossref
T Hoeres, M Wilhelm, M Smetak, E Holzmann, G Schulze-Tanzil & J Birkmann. (2018) Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1. Clinical and Experimental Immunology 192:1, pages 54-67.
Crossref
Crossref
Martin S. Davey, Roshni Malde, Rory C. Mykura, Alfie T. Baker, Taher E. Taher, Cécile S. Le Duff, Benjamin E. Willcox & Youcef Mehellou. (2018)
Synthesis and Biological Evaluation of (
E
)-4-Hydroxy-3-methylbut-2-enyl Phosphate (HMBP) Aryloxy Triester Phosphoramidate Prodrugs as Activators of Vγ9/Vδ2 T-Cell Immune Responses
. Journal of Medicinal Chemistry 61:5, pages 2111-2117.
Crossref
Crossref
Yi-Hsin Lin, Ming-Chieh Yang, Ssu-Hsueh Tseng, Rosie Jiang, Andrew Yang, Emily Farmer, Shiwen Peng, Talia Henkle, Yung-Nien Chang, Chien-Fu Hung & T.-C. Wu. (2018) Integration of Oncogenes via Sleeping Beauty as a Mouse Model of HPV16+ Oral Tumors and Immunologic Control. Cancer Immunology Research 6:3, pages 305-319.
Crossref
Crossref
Lin Xiao, Can Chen, Zhendong Li, Sumin Zhu, Johan Ck Tay, Xi Zhang, Shijun Zha, Jieming Zeng, Wee Kiat Tan, Xin Liu, Wee Joo Chng & Shu Wang. (2018) Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor–modified effector cells. Cytotherapy 20:3, pages 420-435.
Crossref
Crossref
Anna Capsomidis, Gabriel Benthall, Heleen H. Van Acker, Jonathan Fisher, Anne M. Kramer, Zarah Abeln, Yvonne Majani, Talia Gileadi, Rebecca Wallace, Kenth Gustafsson, Barry Flutter & John Anderson. (2018) Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation. Molecular Therapy 26:2, pages 354-365.
Crossref
Crossref
Mohanad H. Nada, Hong Wang, Grefachew Workalemahu, Yoshimasa Tanaka & Craig T. Morita. (2017) Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation. Journal for ImmunoTherapy of Cancer 5:1.
Crossref
Crossref
Moniek A. de Witte, Jürgen Kuball & Jeffrey S. Miller. (2017) NK Cells and γδT Cells for Relapse Protection after Allogeneic Hematopoietic Cell Transplantation (HCT). Current Stem Cell Reports 3:4, pages 301-311.
Crossref
Crossref
Xiaoying Zhou, Yanzheng Gu, Hongying Xiao, Ning Kang, Yonghua Xie, Guangbo Zhang, Yan Shi, Xiaoyu Hu, Eric Oldfield, Xueguang Zhang & Yonghui Zhang. (2017) Combining Vγ9Vδ2 T Cells with a Lipophilic Bisphosphonate Efficiently Kills Activated Hepatic Stellate Cells. Frontiers in Immunology 8.
Crossref
Crossref
Mahboob Salim, Timothy J Knowles, Alfie T. Baker, Martin S. Davey, Mark Jeeves, Pooja Sridhar, John Wilkie, Carrie R. Willcox, Hachemi Kadri, Taher E. Taher, Pierre Vantourout, Adrian Hayday, Youcef Mehellou, Fiyaz Mohammed & Benjamin E. Willcox. (2017)
BTN3A1 Discriminates γδ T Cell Phosphoantigens from Nonantigenic Small Molecules
via
a Conformational Sensor in Its B30.2 Domain
. ACS Chemical Biology 12:10, pages 2631-2643.
Crossref
Crossref
Ignacio Catalan-Serra, Arne Kristian Sandvik, Torunn Bruland & Juan Carlos Andreu-Ballester. (2017) Gammadelta T Cells in Crohn’s Disease: A New Player in the Disease Pathogenesis?. Journal of Crohn's and Colitis 11:9, pages 1135-1145.
Crossref
Crossref
Hung‐Chang Chen, Noémie Joalland, John S Bridgeman, Fouad S Alchami, Ulrich Jarry, Mohd Wajid A Khan, Luke Piggott, Yasmin Shanneik, Jianqiang Li, Marco J Herold, Thomas Herrmann, David A Price, Awen M Gallimore, Richard W Clarkson, Emmanuel Scotet, Bernhard Moser & Matthias Eberl. (2017)
Synergistic targeting of breast cancer stem‐like cells by human γδ T cells and CD8
+
T cells
. Immunology & Cell Biology 95:7, pages 620-629.
Crossref
Crossref
Indrani Dutta, Lynne-Marie Postovit & Gabrielle M. Siegers. (2017) Apoptosis Induced via Gamma Delta T Cell Antigen Receptor “Blocking” Antibodies: A Cautionary Tale. Frontiers in Immunology 8.
Crossref
Crossref
Myriam Lawand, Julie D?chanet-Merville & Marie-Caroline Dieu-Nosjean. (2017) Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications. Frontiers in Immunology 8.
Crossref
Crossref
Jonathan Fisher, Pierre Abramowski, Nisansala Dilrukshi Wisidagamage Don, Barry Flutter, Anna Capsomidis, Gordon Weng-Kit Cheung, Kenth Gustafsson & John Anderson. (2017) Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor. Molecular Therapy 25:5, pages 1234-1247.
Crossref
Crossref
Camille Khairallah, Julie D?chanet-Merville & Myriam Capone. (2017) ?? T Cell-Mediated Immunity to Cytomegalovirus Infection. Frontiers in Immunology 8.
Crossref
Crossref
Aneta Zysk, Mark O. DeNichilo, Vasilios Panagopoulos, Irene Zinonos, Vasilios Liapis, Shelley Hay, Wendy Ingman, Vladimir Ponomarev, Gerald Atkins, David Findlay, Andrew Zannettino & Andreas Evdokiou. (2017) Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer. Cancer Letters 386, pages 141-150.
Crossref
Crossref
Chao Niu, Haofan Jin, Min Li, Shan Zhu, Lei Zhou, Feng Jin, Yulai Zhou, Dongsheng Xu, Jianting Xu, Lianjing Zhao, Shanshan Hao, Wei Li & Jiuwei Cui. (2016) Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma. Oncotarget 8:4, pages 5954-5964.
Crossref
Crossref
Heleen H. Van Acker, Sébastien Anguille, Yannick Willemen, Johan M. Van den Bergh, Zwi N. Berneman, Eva Lion, Evelien L. Smits & Viggo F. Van Tendeloo. (2016) Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells. Journal of Hematology & Oncology 9:1.
Crossref
Crossref
Dieter Kabelitz. (2016) Human γδ T cells: From a neglected lymphocyte population to cellular immunotherapy: A personal reflection of 30years of γδ T cell research. Clinical Immunology 172, pages 90-97.
Crossref
Crossref
Patrik Theodor Nerdal, Christian Peters, Hans-Heinrich Oberg, Hristo Zlatev, Marcus Lettau, Elgar Susanne Quabius, Sofia Sousa, Daniel Gonnermann, Seppo Auriola, Daniel Olive, Jorma Määttä, Ottmar Janssen & Dieter Kabelitz. (2016) Butyrophilin 3A/CD277–Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations. The Journal of Immunology 197:8, pages 3059-3068.
Crossref
Crossref
Rushikesh Sudam Patil, Sagar Umesh Shah, Shailesh Vinayak Shrikhande, Mahesh Goel, Rajesh Prabhakar Dikshit & Shubhada Vivek Chiplunkar. (2016) IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients. International Journal of Cancer 139:4, pages 869-881.
Crossref
Crossref
Hiroki Torikai & Laurence JN Cooper. (2016) Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors. Molecular Therapy 24:7, pages 1178-1186.
Crossref
Crossref
Kathryn S. Sutton, Anindya Dasgupta, David McCarty, Christopher B. Doering & H. Trent Spencer. (2016) Bioengineering and serum free expansion of blood-derived γδ T cells. Cytotherapy 18:7, pages 881-892.
Crossref
Crossref
Dongchun Liang, Aijun Zuo, Ronglan Zhao, Hui Shao, Willi K. Born, Rebecca L. O'Brien, Henry J. Kaplan & Deming Sun. (2016) CD73 Expressed on γδ T Cells Shapes Their Regulatory Effect in Experimental Autoimmune Uveitis. PLOS ONE 11:2, pages e0150078.
Crossref
Crossref
Francesca Toia, Simona Buccheri, Ampelio Anfosso, Francesco Moschella, Francesco Dieli, Serena Meraviglia & Adriana Cordova. (2016) Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome. PLOS ONE 11:2, pages e0149570.
Crossref
Crossref
Shiori Sugai, Toshiaki Yoshikawa, Tatsuaki Iwama, Nobuhiro Tsuchiya, Norihiro Ueda, Norihiro Fujinami, Manami Shimomura, Rong Zhang, Shin Kaneko, Yasushi Uemura & Tetsuya Nakatsura. (2016) Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate. International Journal of Oncology.
Crossref
Crossref
Ho Joon ImKyung-Nam KohJong Jin Seo. (2016)
Recent advances in haploidentical hematopoietic stem cell transplantation using
ex vivo
T cell-depleted graft in children and adolescents
. Blood Research 51:1, pages 8.
Crossref
Crossref
Hirohito Kobayashi & Hitoshi Kanno. (2016) THE APPLICATION FOR CANCER IMMUNOTHERAPY USING <i>in vivo</i> OR <i>in vitro</i> ACTIVATED γδ T CELL. Japanese Journal of Transfusion and Cell Therapy 62:1, pages 3-12.
Crossref
Crossref
Xuan Sun, Jian Suo & Jun Yan. (2016) Immunotherapy in human colorectal cancer: Challenges and prospective. World Journal of Gastroenterology 22:28, pages 6362.
Crossref
Crossref
Vivek Mittal, Tina El Rayes, Navneet Narula, Timothy E. McGraw, Nasser K Altorki & Mary Helen Barcellos-Hoff. 2016. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management
75
110
.
Chao Niu, Haofan Jin, Min Li, Jianting Xu, Dongsheng Xu, Jifan Hu, Hua He, Wei Li & Jiuwei Cui. (2015) In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells. BMC Immunology 16:1.
Crossref
Crossref
Teruyo Arato, Takashi Daimon, Yuji Heike, Ken Ishii, Kyogo Itho, Shinichi Kageyama, Yutaka Kawakami, Eiichi Nakayama, Keiya Ozawa, Noriyuki Sato, Hiroshi Shiku, Masahiro Takeuchi, Kenzaburo Tani, Koji Tamada, Ryuzo Ueda, Yoshiyuki Yamaguchi, Takeharu Yamanaka, Hiroki Yamaue, Masaki Yasukawa, Toyotaka Iguchi, Shigehisa Kitano, Yoshihiro Miyahara, Yasuhiro Nagata, Masanori Noguchi, Takeshi Terashima, Takeo Asano, Motohiro Asonuma, Hiroaki Ikeda, Kazuhiro Kakimi, Kazutoh Takesako, Masanori Tanaka, Kohei Amakasu, Akira Yamada, Naozumi Harada, Taiki Aoshi, Etsushi Kuroda, Kouji Kobiyama, Daisuke Muraoka, Naoya Yamazaki, Aya Kuchiba, Shiro Tanaka, Hirofumi Michimae, Tomomi Yamada, Kenichi Hanada, Hideho Okada, Naoko Takebe, Naoto Hirano, Satoshi Okumura, Daisaku Sato, Masayoshi Shibatsuji & Teruhide Yamaguchi. (2015) 2015 Guidance on cancer immunotherapy development in early‐phase clinical studies. Cancer Science 106:12, pages 1761-1771.
Crossref
Crossref
Jun Imagawa, Hideo Tanaka, Masaya Okada, Hirohisa Nakamae, Masayuki Hino, Kazunori Murai, Yoji Ishida, Takashi Kumagai, Seiichi Sato, Kazuteru Ohashi, Hisashi Sakamaki, Hisashi Wakita, Nobuhiko Uoshima, Yasunori Nakagawa, Yosuke Minami, Masahiro Ogasawara, Tomoharu Takeoka, Hiroshi Akasaka, Takahiko Utsumi, Naokuni Uike, Tsutomu Sato, Sachiko Ando, Kensuke Usuki, Satoshi Morita, Junichi Sakamoto & Shinya Kimura. (2015) Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial. The Lancet Haematology 2:12, pages e528-e535.
Crossref
Crossref
Piyanuch Kongtim, Dean A. Lee, Laurence J.N. Cooper, Partow Kebriaei, Richard E. Champlin & Stefan O. Ciurea. (2015) Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular Therapy. Biology of Blood and Marrow Transplantation 21:10, pages 1714-1720.
Crossref
Crossref
Amélie Lombes, Aurélie Durand, Céline Charvet, Matthieu Rivière, Nelly Bonilla, Cédric Auffray, Bruno Lucas & Bruno Martin. (2015) Adaptive Immune-like γ/δ T Lymphocytes Share Many Common Features with Their α/β T Cell Counterparts. The Journal of Immunology 195:4, pages 1449-1458.
Crossref
Crossref
Jaydeep Bhat, Hans-Heinrich Oberg & Dieter Kabelitz. (2015) Modulation of human gamma/delta T-cell activation and phenotype by histone deacetylase inhibitors. Cellular Immunology 296:1, pages 50-56.
Crossref
Crossref
Christopher J. Tyler, Derek G. Doherty, Bernhard Moser & Matthias Eberl. (2015) Human Vγ9/Vδ2 T cells: Innate adaptors of the immune system. Cellular Immunology 296:1, pages 10-21.
Crossref
Crossref
Kanako Shimizu, Jun Shinga, Satoru Yamasaki, Masami Kawamura, Jan Dörrie, Niels Schaft, Yusuke Sato, Tomonori Iyoda & Shin-ichiro Fujii. (2015) Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells. PLOS ONE 10:6, pages e0131477.
Crossref
Crossref
Seng-Ryong Woo, Leticia Corrales & Thomas F. Gajewski. (2015) Innate Immune Recognition of Cancer. Annual Review of Immunology 33:1, pages 445-474.
Crossref
Crossref
Lionel Couzi, Vincent Pitard, Jean-François Moreau, Pierre Merville & Julie Déchanet-Merville. (2015) Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation. Frontiers in Immunology 6.
Crossref
Crossref
Drew C. Deniger, Judy S. Moyes & Laurence J. N. Cooper. (2014) Clinical Applications of Gamma Delta T Cells with Multivalent Immunity. Frontiers in Immunology 5.
Crossref
Crossref
Wouter Scheper, Zsolt Sebestyen & Jürgen Kuball. (2014) Cancer Immunotherapy Using γδT Cells: Dealing with Diversity. Frontiers in Immunology 5.
Crossref
Crossref
Julie Déchanet-Merville. (2014) Promising Cell-Based Immunotherapy Using Gamma Delta T Cells: Together Is Better. Clinical Cancer Research 20:22, pages 5573-5575.
Crossref
Crossref
Matthias Eberl, Ida M. Friberg, Anna Rita Liuzzi, Matt P. Morgan & Nicholas Topley. (2014) Pathogen-Specific Immune Fingerprints during Acute Infection: The Diagnostic Potential of Human γδ T-Cells. Frontiers in Immunology 5.
Crossref
Crossref
Alessandro Poggi & Maria Raffaella Zocchi. (2014) γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy. Frontiers in Immunology 5.
Crossref
Crossref
T. Sree Latha, Madhava C. Reddy, Prasad V. R. Durbaka, Aparna Rachamallu, Reddanna Pallu & Dakshayani Lomada. (2014) γδ T Cell-Mediated Immune Responses in Disease and Therapy. Frontiers in Immunology 5.
Crossref
Crossref
Kenth Gustafsson, John Anderson, Jonathan P.H. Fisher & Mengyong Yan. (2014) Regeneration of stalled immune responses to transformed and infected cells using γδ T cells. Drug Discovery Today 19:6, pages 787-793.
Crossref
Crossref